About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Radiopharmaceutical Chemistry
›
top-articles
Division of Radiopharmaceutical Chemistry
25
(top 2%)
papers
3.9K
(top 1%)
citations
20
(top 1%)
h
-index
26
(top 2%)
g
-index
26
all documents
4.1K
doc citations
507
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging
2015
866
2
225
Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine
2016
741
3
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
European Journal of Nuclear Medicine and Molecular Imaging
2017
425
4
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
Journal of Nuclear Medicine
2015
332
5
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer
Journal of Nuclear Medicine
2016
200
6
Preclinical Evaluation of
18
F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
Journal of Nuclear Medicine
2017
186
7
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
Journal of Medicinal Chemistry
2016
150
8
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging
2016
148
9
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
European Journal of Nuclear Medicine and Molecular Imaging
2016
143
10
Intraindividual Comparison of
18
F-PSMA-1007 and
18
F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
Journal of Nuclear Medicine
2018
140
11
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI
European Journal of Nuclear Medicine and Molecular Imaging
2017
124
12
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging
2018
116
13
Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
Journal of Nuclear Medicine
2017
111
14
The Clinical Impact of Additional Late PET/CT Imaging with
68
Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
Journal of Nuclear Medicine
2017
105
15
PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers’ pharmacokinetics
European Journal of Nuclear Medicine and Molecular Imaging
2014
55
16
18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer
Clinical Genitourinary Cancer
2017
47
17
Response Prediction of
177
Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
Journal of Nuclear Medicine
2020
39
18
Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study
European Journal of Nuclear Medicine and Molecular Imaging
2018
32
19
Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT
European Journal of Nuclear Medicine and Molecular Imaging
2018
26
20
Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management
Journal of Nuclear Medicine
2020
26
21
Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes
Journal of Nuclear Medicine
2020
23
22
Development of PSMA-1007-Related Series of
18
F-Labeled Glu-Ureido-Type PSMA Inhibitors
Journal of Medicinal Chemistry
2020
18
23
Effects of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 (HBED-CC) PET/MRI
European Journal of Nuclear Medicine and Molecular Imaging
2017
17
24
Impact of
18
F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice
Journal of Nuclear Medicine
2019
15
25
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies
Cancer Research
2021
11
site/software ©
exaly
; All materials licenced under
CC by-SA
.